Press release
Non-Alcoholic Steatohepatitis Market Overview 2023, Demand by Regions, Share and Forecast to 2028
Non-alcoholic steatohepatitis (NASH) is a liver condition characterized by inflammation and the accumulation of fat deposits in the liver, absent of excessive alcohol consumption. It is a severe form of non-alcoholic fatty liver disease (NAFLD) and can progress to more critical liver diseases such as cirrhosis and liver cancer if left untreated. NASH is often asymptomatic in its early stages, making it difficult to diagnose without specific tests. It typically affects individuals with obesity, type 2 diabetes, or high cholesterol levels. Due to its chronic nature, the management of NASH generally involves lifestyle changes and may require pharmacological intervention. Given the implications on long-term liver health and the increasing prevalence of NASH, there is a growing necessity for effective treatments and diagnostic methods within the healthcare industry.
Request Your Sample Report Now: https://www.imarcgroup.com/non-alcoholic-steatohepatitis-market/requestsample
Non-Alcoholic Steatohepatitis (NASH) Market Trends and Drivers:
The global non-alcoholic steatohepatitis (NASH) market is primarily driven by the rising incidence of obesity and type 2 diabetes worldwide, both of which are risk factors for developing NASH. As awareness around the condition grows, more healthcare facilities are focusing on early diagnosis and treatment, which in turn fuels the market for NASH-related pharmaceuticals and diagnostic tools. Additionally, ongoing research and development (R&D) in the sector aims to bring more targeted treatments to the market, potentially offering better patient outcomes. In line with this, the increasing adoption of sedentary lifestyles has contributed to the uptick in NASH cases, prompting greater emphasis on preventative healthcare measures, thus propelling market growth. Furthermore, advancements in liver biopsy techniques and imaging studies are providing a positive thrust to the diagnosis sector within the industry, thereby contributing to market growth.
Report Segmentation:
The report has segmented the market into the following categories:
Drug Type Insights:
Vitamin E and Pioglitazone
Ocaliva
Elafibranor
Selonsertib
Cenicriviroc
Others
Disease Cause Insights:
Hypertension
Heart Disease
High Blood Lipid
Type 2 Diabetes
Obesity
Sales Channel Insights:
Hospital Pharmacy
Online Providers
Retail Pharmacy
End User Insights:
Hospitals
Clinics
Homecare Settings
Market Breakup by Region:
North America (United States, Canada)
Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa
Competitive Landscape with Key Player:
Algernon Pharmaceuticals
Galmed Pharmaceuticals Ltd
Intercept Pharmaceuticals Inc.
Zydus Lifesciences Limited
Explore full report with table of contents: https://www.imarcgroup.com/non-alcoholic-steatohepatitis-market
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
Contact Us
IMARC Group
Email: sales@imarcgroup.com
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Follow us on Twitter: @imarcglobal
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Non-Alcoholic Steatohepatitis Market Overview 2023, Demand by Regions, Share and Forecast to 2028 here
News-ID: 3281796 • Views: …
More Releases from IMARC Group
U.S. eyewear market: Size, Trends, Growth and Forecast 2026-2034
IMARC Group has recently released a new research study titled "U.S. Eyewear Market Report by Product (Spectacles, Sunglasses, Contact Lenses), Gender (Men, Women, Unisex), Distribution Channel (Optical Stores, Independent Brand Showrooms, Online Stores, Retail Stores), and Region 2026-2034", offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends and competitive landscape to understand the current and future market scenarios.
Market Overview
The U.S. eyewear market size reached USD 40.8 Billion…
United States digital OOH advertising market: Size, Growth, Latest Trends and Fo …
IMARC Group has recently released a new research study titled "United States Digital OOH Advertising Market Report by Format Type (Digital Billboards, Video Advertising, Ambient Advertising, and Others), Application (Outdoor, Indoor), End Use Industry (Retail, Recreation, Banking, Transportation, Education, and Others), and Region 2025-2033", offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends and competitive landscape to understand the current and future market scenarios.
Market Overview
The United States…
Mexico Grid Modernization Market Share, Size, In-Depth Analysis and Forecast 202 …
IMARC Group has recently released a new research study titled "Mexico Grid Modernization Market Size, Share, Trends and Forecast by Component, Application, End-User, and Region, 2025-2033" which offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends, and competitive landscape to understand the current and future market scenarios.
Market Overview
The Mexico grid modernization market size was valued at USD 568.18 Million in 2024. The market is projected to reach…
Cosmetics Market is Expected to Reach USD 629.7 Billion by 2033 | At CAGR 4.6%
Cosmetics Market Overview:
The global Cosmetics Market was valued at USD 419.8 Billion in 2024 and is projected to reach USD 629.7 Billion by 2033, growing at a CAGR of 4.6% during 2025-2033. The market is propelled by growing personal grooming trends, the advent of advanced product variants, rising demand for vegan cosmetics, and expanded product availability on e-commerce platforms.
The global cosmetics market size continues to grow steadily, driven by rising…
More Releases for NASH
The Growing Demand For NASH Treatment Amid Obesity Epidemic: A Key Catalyst Acce …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Non-Alcoholic Steatohepatitis (NASH) Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for non-alcoholic steatohepatitis (NASH) has seen a considerable expansion in the past few years. Its value is expected to rise from $4.5 billion in 2024 to $6.06 billion in 2025, marking…
Nonalcoholic Steatohepatitis (NASH) Market Massive Growth opportunity Ahead
Introduction
Nonalcoholic Steatohepatitis (NASH) is an advanced form of nonalcoholic fatty liver disease (NAFLD) characterized by fat accumulation in the liver along with inflammation and liver cell damage. If left untreated, NASH can progress to fibrosis, cirrhosis, liver failure, or hepatocellular carcinoma. Closely tied to the global obesity and diabetes epidemic, NASH has become a major healthcare burden, with millions affected worldwide and no widely approved curative therapy to date.
The NASH…
Non Alcoholic Steatohepatitis (NASH) Market Size to Hit $21,879 Million by 2028 …
According to our experience research team, Non Alcoholic Steatohepatitis (NASH) Market was valued at USD 1,569 Million in 2021, and the global Non Alcoholic Steatohepatitis (NASH) industry is projected to reach a value of USD 21,879 Million by 2028, at a CAGR of 60.4% during the forecast period 2022-2028
The report is focused on gaining various Non Alcoholic Steatohepatitis (NASH) market trends, dynamics, growth drivers, opportunities, weaknesses, strengths, and threats restraining…
NASH Market Insight and Landscape report
Report Snapshot:
NASH is one of the furthermost causes of liver disease worldwide and will probably emerge as the leading cause of end-stage liver disease in the coming years, with the disease affecting both adults and children. The epidemiology and demographic characteristics of NASH vary across different country level. Furthermore, individuals with NAFLD have a high frequency of metabolic comorbidities and could place a growing strain on health-care systems from their…
Nash releases debut EP 'She Don't Know'
London-based singer/songwriter Nash has released his debut EP She Don’t Know. Recorded at the legendary RAK Studios, She Don’t Know has the feel of 60s rock but with a modern twist, leaving the listener hooked throughout and wanting to come back for another listen. She Don’t Know’s leading single CK is an infectious number which is sure to be a hit for 2017.
Listening to the Beatles and Jack White growing…
Nash Technologies at GITEX/GULFCOMMS 2010
Harvey Nash subsidiary presents expert services to telecom operators in the Middle East, Africa and South Asia region
Nürnberg/Germany, 10th September 2010 – For the first time Nash Technologies will be present at GITEX/GULFCOMMS, the largest international trade event for mobile, fixed, IP and satellite communications for the Middle East, Africa and South Asia region, in Dubai from 17th to 21st October 2010 offering its telecom expert services. Nash Technologies will…
